Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dabholkar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Letters|April 15, 1992
Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell linesM Dabholkar, E Reed
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
CisplatinM Dabholkar, E Reed
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
CisplatinM Dabholkar, E Reed
Mutation Research|June 1, 1992
Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell linesM Dabholkar, R Parker, E Reed
Carcinogenesis|October 1, 1990
Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell lineM Dabholkar, A Eastman, E Reed
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
CisplatinM Dabholkar, M Christian, E Reed
Leukemia Research|January 1, 1986
Natural and antibody-dependent cellular cytotoxicity in chronic myeloid leukemia patients in remissionM Dabholkar, S Advani, R Tatake, et al.
Oncology|January 1, 1989
Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remissionM Dabholkar, R Tatake, K Amin, et al.
International Journal of Oncology|May 17, 2011
Platinum-DNA adduct in head and neck-cancer patients receiving Cisplatin and Carboplatin chemotherapyR Parker, I Dimery, M Dabholkar, et al.
Neoplasma|January 1, 1990
Studies on natural killer cells in chronic myeloid leukemia patients in remissionM Dabholkar, R J Tatake, S Advani, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Letters|April 15, 1992
Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell linesM Dabholkar, E Reed
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
CisplatinM Dabholkar, E Reed
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
CisplatinM Dabholkar, E Reed
Mutation Research|June 1, 1992
Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell linesM Dabholkar, R Parker, E Reed
Carcinogenesis|October 1, 1990
Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell lineM Dabholkar, A Eastman, E Reed
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
CisplatinM Dabholkar, M Christian, E Reed
Leukemia Research|January 1, 1986
Natural and antibody-dependent cellular cytotoxicity in chronic myeloid leukemia patients in remissionM Dabholkar, S Advani, R Tatake, et al.
Oncology|January 1, 1989
Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remissionM Dabholkar, R Tatake, K Amin, et al.
International Journal of Oncology|May 17, 2011
Platinum-DNA adduct in head and neck-cancer patients receiving Cisplatin and Carboplatin chemotherapyR Parker, I Dimery, M Dabholkar, et al.
Neoplasma|January 1, 1990
Studies on natural killer cells in chronic myeloid leukemia patients in remissionM Dabholkar, R J Tatake, S Advani, et al.
Pageof 3